Stockscreener 앱 받기
59.54
6.16%
-3.91
시간 외 거래:
59.54
Bio Techne Corp 주식(TECH)의 최신 뉴스
(TECH) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
5 Insightful Analyst Questions From Bio-Techne's Q4 Earnings Call - Finviz
There May Be Reason For Hope In Bio-Techne's (NASDAQ:TECH) Disappointing Earnings - Yahoo Finance
What Are Wall Street Analysts' Target Price for Bio-Techne Stock? - inkl
Bio-Techne Announces Changes to its Leadership Team - Investing News Network
Ex-Dividend Reminder: Bio-Techne, 3M and Eli Lilly - Nasdaq
Madison Asset Management LLC Acquires Shares of 744,651 Bio-Techne Corp $TECH - MarketBeat
Bio-Techne (NASDAQ:TECH) Stock Rating Upgraded by Zacks Research - MarketBeat
Bio-Techne Corp (NASDAQ:TECH) Passes Key Quality Investing Screen - ChartMill
Baader Bank Aktiengesellschaft Buys 38,082 Shares of Bio-Techne Corp $TECH - MarketBeat
Bio-Techne: How Spatial Biology Innovation Is Powering a Strategic Comeback! - Smartkarma
Azzad Asset Management Inc. ADV Has $774,000 Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
How Flat Sales, Higher EPS, and New Organoid Tools At Bio-Techne (TECH) Have Changed Its Investment Story - Yahoo Finance
Bio-Techne stock price target raised to $65 from $60 at Stifel By Investing.com - Investing.com Nigeria
New York State Common Retirement Fund Sells 465,634 Shares of Bio-Techne Corp $TECH - MarketBeat
Bio-Techne stock price target raised to $65 from $60 at Stifel - Investing.com UK
Wells Fargo & Company Issues Positive Forecast for Bio-Techne (NASDAQ:TECH) Stock Price - MarketBeat
TECH Stock Update: Wells Fargo Raises Price Target for Bio-Techne | TECH Stock News - GuruFocus
Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Cor - GuruFocus
Bio-Techne (TECH) Sees Target Price Raised by Stifel | TECH Stoc - GuruFocus
UBS Maintains Buy Rating on Bio-Techne (TECH) with Raised Price Target | TECH Stock News - GuruFocus
Citigroup Raises Price Target for Bio-Techne (TECH) to $80.00 | - GuruFocus
7 Analysts Assess Bio-Techne: What You Need To Know - Benzinga
Assessing Bio-Techne (TECH) Valuation After Earnings Beat And New Research Product Launches - simplywall.st
Tech Stock Update: Evercore ISI Group Raises Price Target for TE - GuruFocus
TD Cowen Maintains Buy Rating on Bio-Techne (TECH) and Raises Pr - GuruFocus
Leerink Partners Adjusts Price Target on Bio-Techne to $80 From $75, Maintains Outperform Rating - marketscreener.com
Bio-Techne Corporation (NASDAQ:TECH) Q2 2026 Earnings Call Transcript - Insider Monkey
Techne Corp. (TECH) Q2 Earnings Report: Results Top Analyst ForecastsNews and Statistics - IndexBox
TECH Q4 Deep Dive: Margin Expansion and Flat Revenue Amid Mixed End Markets - Finviz
Trading Recap: Is Bio Techne Corporation showing insider buying2025 Analyst Calls & Advanced Technical Signal Analysis - baoquankhu1.vn
Bio-Techne (NASDAQ:TECH) Surprises With Q4 CY2025 Sales - The Globe and Mail
Bio-Techne Corp Plans Quarterly Dividend of $0.08 (NASDAQ:TECH) - MarketBeat
Bio-Techne Releases Second Quarter Fiscal 2026 Results - Investing News Network
Bio-Techne Corp (TECH) Q2 2026 Earnings Call Highlights: Strateg - GuruFocus
Bio-Techne (NASDAQ:TECH) Shares Up 7% on Strong Earnings - MarketBeat
Earnings call transcript: Bio-Techne beats Q2 2026 EPS and revenue forecasts - Investing.com Nigeria
Biotech firm Bio-Techne beats quarterly estimates on strength in key unit - marketscreener.com
Bio-Techne (TECH) Q2 2026 Earnings Call Transcript - The Globe and Mail
Bio-Techne Q2 2026 Earnings Call Transcript - MarketBeat
Bio-Techne (NASDAQ:TECH) Announces Quarterly Earnings Results - MarketBeat
Bio-techne announces $0.08 quarterly dividend payment By Investing.com - Investing.com South Africa
TECH Q2 Earnings & Revenues Beat Estimates, Operating Margin Up - Yahoo Finance
Bio-Techne Corp announces dividend of $0.08 per share for Q4 2025 - marketscreener.com
Bio-Techne Fiscal Q2 Adjusted Earnings Rise, Revenue Falls - marketscreener.com
Bio-Techne (TECH) Surpasses Q2 Revenue Expectations - GuruFocus
Insights into Bio-Techne Q2 Earnings - Benzinga
Bio-Techne Corp (NASDAQ:TECH) Reports Q2 Earnings Beat, Meets Revenue Forecasts - ChartMill
Bio-Techne Corporation Declares Dividend for the Quarter Ended December 31, 2025, Payable on February 27, 2026 - marketscreener.com
Bio-Techne Earnings Review: Q2 Summary - Benzinga
Earnings Breakdown: Bio-Techne Q2 - Benzinga
Bio-Techne Earnings Report: Q2 Overview - Benzinga
Bio-techne announces $0.08 quarterly dividend payment - Investing.com
Bio-Techne beats expectations as adjusted EPS rises 10% By Investing.com - Investing.com South Africa
Bio-Techne beats expectations as adjusted EPS rises 10% - Investing.com
Bio-Techne earnings beat by $0.03, revenue topped estimates - Investing.com
Bio-Techne: Q2 Earnings Insights - Benzinga
Bio-Techne Q2 Earnings Report: What Investors Need to Know - Benzinga
Bio-Techne Corp. Q2 Profit Climbs - Nasdaq
Earnings Flash (TECH) Bio-Techne Corporation Posts Q2 Adjusted EPS $0.46 per Share, vs. FactSet Est of $0.43 - marketscreener.com
1.24%
0.19%
자본화:
|
볼륨(24시간):